Posts Tagged ‘flibanserin’

The year in clinical sexuality, 2010

As we get ready to close the books on 2010, I would like to express my gratitude to  family,  friends, and colleagues for your support and encouragement over the past year.   And to all my patients for your trust and confidence.   May we all merit much happiness in 2011. In ending the year, [...]

Pink Viagra + the Riddle of Female Sexual Desire

    Sex Therapy, Flibanserin, and the FDA October 29, 2014.    As many of you know, in 2010 Boehringer Ingelheim failed to win approval from the FDA committee charged with evaluating flibanserin for something called Hypoactive Sexual Desire Disorder (HSDD) in women. At the time, many observers argued that HSDD was a made-up disorder, invented [...]

Our sexual culture and The New York Times

The latest public figure to make journalistic hay from the flibanserin controversy is Camille Paglia, whose editorial in The New York Times, ”No Sex Please, We’re Middle Class, “ seems to be getting some play on my twitter feed.   It’s a fun read, but she throws a lot of things together that I’m not sure really [...]

Simplicity, complexity, and the hunt for Pink Viagra

  Oct 27, 2014   Will there ever be a “Viagra for women?”    If so, would it ever make it past the FDA?  And how many would women would really ever want to take it? In 2010, an FDA committee voted not to approve Boehringer-Ingelheim’s  flibanserin — a medication reported to somewhat improve female [...]